Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Corcept Therapeutics Inc. (GB:0I3Q)
LSE:0I3Q
Corcept Therapeutics (0I3Q) Ownership - Who Owns Corcept Therapeutics?
0 Followers
Corcept Therapeutics (0I3Q) Ownership Overview
0.00% Insiders
0.00% Mutual Funds
4.19% Other Institutional Investors
95.81% Public Companies and
Individual Investors
The ownership structure of Corcept Therapeutics (GB:0I3Q) stock is a mix of institutional, retail and individual investors. Approximately 4.19% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 95.81% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 20, 2023 | Sold | $163650 | |
| Sep 18, 2023 | Bought | $45938 | |
| Sep 06, 2023 | Joseph Douglas Lyon Chief Accounting & Technology Officer | Sold | $163650 |
| Sep 06, 2023 | Daniel Swisher Director | Sold | $123112 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $262893 | |
| Dec 31, 2023 | Bought | $291800 | |
| Dec 31, 2023 | Sold | $573694 | |
| Dec 31, 2023 | Sold | $1705200 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 50,000 | Insider | ― | 1,200,750 | |
| 194,958 | Insider | ― | 4,681,916 | |
| 45,303 | Insider | ― | 1,087,952 | |
| 10,000 | Insider | ― | 240,150 | |
| 14,711,890 | Insider | ― | 353,306,038 | |
| 2,600,291 | Insider | ― | 62,445,988 | |
| 5,310,196 | Insider | ― | 127,524,357 | |
| 2,217,093 | Insider | ― | 53,243,488 | |
| 1,286,567 | Insider | ― | 30,896,907 | |
| 2,831,918 | Insider | ― | 68,008,511 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 143,200 | Institution | ― | 3,438,948 | |
| 6,870 | Institution | ― | 164,983 | |
| 58,650 | Institution | ― | 1,408,480 | |
| 4,066 | Institution | ― | 97,645 | |
| 7,695 | Institution | ― | 184,795 | |
| 300,614 | Institution | ― | 7,219,245 | |
| 45,003 | Institution | ― | 1,080,747 | |
| 46,230 | Institution | ― | 1,110,213 | |
| 14,251 | Institution | ― | 342,238 | |
| 3,287 | Institution | ― | 78,937 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Corcept Therapeutics Inc. (GB:0I3Q)?
According to the latest TipRanks data, approximately 4.19% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 95.81% is held by retail investors.
What percentage of Corcept Therapeutics Inc. (GB:0I3Q) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.19% of Corcept Therapeutics Inc. (GB:0I3Q) stock is held by institutional investors.
What percentage of Corcept Therapeutics Inc. (GB:0I3Q) stock is held by retail investors?
According to the latest TipRanks data, approximately 95.81% of Corcept Therapeutics Inc. (GB:0I3Q) stock is held by retail investors.
Who owns the most shares of Corcept Therapeutics Inc. (GB:0I3Q)?
Anne Ledoux owns the most shares of Corcept Therapeutics Inc. (GB:0I3Q).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.